|Register||Search||Today's Posts||Mark Forums Read|
|Transfection Forum Transfection Forum. Cell transfection discussion including stable cells transfection, transient transfection. Troubleshooting and posting of discussions on lipofection, and reagents: Fugene, lipofectamine, and others.|
| ||LinkBack||Thread Tools||Display Modes|
MG132 cell treatment and toxicity problem.
I use MG132 (a potent proteasomal inhibitor) to prevent/reduce the degradation of proteins by ubiquitin-proteasome machinery.
i am using 10uM of MG132 for 10 hrs but I observe 2 unwanted effects: 1) MG132 shows some cell toxicity and I lose ~30-40% of my cells. 2) MG132 itself targets my protein of interest and I do not see any effect of MG132 on the stability of my protein of interest.
I appreciate your suggestion.
Re: MG132 cell treatment and toxicity problem.
It may be too late for you, but for anyone being in trouble with MG132, you can try to treat your cells at a molarity ranging from 10ÁM to 20ÁM for ~4 hours. In my team, the routine treatment is 20ÁM, 4 hours, and we sometimes lower the concentration, depending on the cell line (20ÁM may still be toxic to some cells even with decreased treatment duration).
Otherwise, regarding the effect of MG132 itself towards a studied protein, one may want to use another inhibitor which is more proteasome activity-specific, such as lactacystin or epoxomicin.The drawback is that these inhibitors are far more expensive than MG132 is.
|cell , mg132 , problem , toxicity , treatment|
|Thread||Thread Starter||Forum||Replies||Last Post|
|Human Cytome Project - Update 24 Jan. 2005||Peter Van Osta||Cell Biology and Cell Culture||1||08-01-2010 02:18 PM|
|aspartame toxicity coverup increases danger of corporate meltdown:||Rich Murray||Chemistry Forum||1||07-19-2009 01:19 PM|
|Human Cytome Project - How to explore - Update 19 April 2005||Peter Van Osta||Cell Biology and Cell Culture||0||04-19-2005 07:10 AM|
|Human Cytome Project - Update 6 Jan. 2005||Peter Van Osta||Cell Biology and Cell Culture||0||01-06-2005 10:18 AM|
|Tissue Engineering & Stem Cell Research 2005||Andrew Oliver||Protocols and Methods Forum||0||12-02-2004 10:38 PM|